Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Global Medical REIT Inc shares valued at $669,694 were purchased by Decker Mark Okey Jr on Jun 24 ’25. At $6.52 per share, Decker Mark Okey Jr acquired 102,668 shares. The insider’s holdings grew to 102,668 shares worth approximately $0.68 million following the completion of this transaction.
Also, Decker Mark Okey Jr purchased 57,332 shares, netting a total of over 372,834 in proceeds. Following the buying of shares at $6.50 each, the insider now holds 160,000 shares.
Analysts at Berenberg started covering the stock with ‘”a Buy”‘ outlook in a report released in mid October. As of September 19, 2024, Alliance Global Partners has initiated its “Buy” rating for GMRE. Earlier on October 10, 2022, Robert W. Baird downgraded its rating. Their new recommendation was “a Neutral” for GMRE stock which previously was a “an Outperform”.
Analyzing GMRE Stock Performance
On last trading session, Global Medical REIT Inc [NYSE: GMRE] rose 2.62% to $6.67. The stock’s lowest price that day was $6.5, but it reached a high of $6.8 in the same session. During the last five days, there has been a drop of approximately -0.15%. Over the course of the year, Global Medical REIT Inc shares have dropped approximately -25.74%.
Is Global Medical REIT Inc subject to short interest?
Stocks of Global Medical REIT Inc saw a sharp rise in short interest on 2025-07-15 jumping by 0.65 million shares to 2.65 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 2.0 million shares. A jump of 24.47% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.95 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.95.
Which companies own the most shares of Global Medical REIT Inc (GMRE)?
In terms of Global Medical REIT Inc share price expectations, FactSet research, analysts set an average price target of 11 in the next 12 months, up nearly 69.23% from the previous closing price of $6.5. Analysts anticipate Global Medical REIT Inc stock to reach 11 by 2025, with the lowest price target being 11. In spite of this, 1 analysts ranked Global Medical REIT Inc stock as Buy at the end of 2025. On October 06, 2022, BMO Capital Markets assigned a price target of “a Market perform” to the stock and downgraded coverage with a $9.
